Estrogen and mitochondria: A new paradigm for vascular protection?

被引:77
作者
Duckles, SP [1 ]
Krause, DN
Stirone, C
Procaccio, V
机构
[1] Univ Calif Irvine, Sch Med, Dept Pharmacol, Irvine, CA 92717 USA
[2] Univ Calif Irvine, Sch Med, Dept Pediat, Irvine, CA 92717 USA
[3] Univ Calif Irvine, Sch Med, Ctr Mitochondrial & Mol Med & Genet, Irvine, CA 92717 USA
关键词
D O I
10.1124/mi.6.1.6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Mitochondrial dysfunction has been implicated as a cause of age-related disorders, and the mitochondrial theory of aging links aging, exercise, and diet. Endothelial dysfunction is a key paradigm for vascular disease and aging, and there is considerable evidence that exercise and dietary restriction protect against cardiovascular disease. Recent studies demonstrate that estrogen receptors are present in mitochondria and that estrogen promotes mitochondrial efficiency and decreases oxidative stress in the cerebral vasculature. Chronic estrogen treatment increases mitochondrial capacity for oxidative phosphorylation while decreasing production of reactive oxygen species. The effectiveness of estrogen against age-related cardiovascular disorders, including stroke, may thus arise in part from hormonal effects on mitochondrial function. Estrogen-mediated mitochondrial efficiency may also be a contributing factor to the longer lifespan of women.
引用
收藏
页码:26 / 35
页数:10
相关论文
共 72 条
[1]
ALSHAER M, 2005, INT J CARDIOL 0726
[2]
Vasomotor responses in MnSOD-deficient mice [J].
Andresen, JJ ;
Faraci, FM ;
Heistad, DD .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (03) :H1141-H1148
[3]
H2O2 generation in Saccharomyces cerevisiae respiratory pet mutants:: Effect of cytochrome c [J].
Barros, MH ;
Netto, LES ;
Kowaltowski, AJ .
FREE RADICAL BIOLOGY AND MEDICINE, 2003, 35 (02) :179-188
[4]
Mechanisms of aging-induced impairment of endothelium-dependent relaxation: role of tetrahydrobiopterin [J].
Blackwell, KA ;
Sorenson, JP ;
Richardson, DM ;
Smith, LA ;
Suda, O ;
Nath, K ;
Katusic, ZS .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (06) :H2448-H2453
[5]
Investigative models for determining hormone therapy-induced outcomes in brain - Evidence in support of a healthy cell bias of estrogen action. [J].
Brinton, RD .
FUTURE OF HORMONE THERAPY: WHAT BASIC SCIENCE AND CLINICAL STUDIES TEACH US, 2005, 1052 :57-74
[6]
Estrogen: A mitochrondrial energizer that keeps on going [J].
Burris, TP ;
Krishnan, V .
MOLECULAR PHARMACOLOGY, 2005, 68 (04) :956-958
[7]
Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors α and β to human mitochondrial DNA estrogen response elements [J].
Chen, JQ ;
Eshete, M ;
Alworth, WL ;
Yager, JD .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 93 (02) :358-373
[8]
Production of reactive oxygen species by mitochondria - Central role of complex III [J].
Chen, Q ;
Vazquez, EJ ;
Moghaddas, S ;
Hoppel, CL ;
Lesnefsky, EJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) :36027-36031
[9]
The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes [J].
Chomyn, A ;
Enriquez, JA ;
Micol, V ;
Fernandez-Silva, P ;
Attardi, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (25) :19198-19209
[10]
Mitochondrial genes as sites of primary action of steroid hormones [J].
Demonacos, CV ;
Karayanni, N ;
Hatzoglou, E ;
Tsiriyiotis, C ;
Spandidos, DA ;
Sekeris, CE .
STEROIDS, 1996, 61 (04) :226-232